ID   KPCG_HUMAN              Reviewed;         697 AA.
AC   P05129;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 3.
DT   02-NOV-2010, entry version 132.
DE   RecName: Full=Protein kinase C gamma type;
DE            Short=PKC-gamma;
DE            EC=2.7.11.13;
GN   Name=PRKCG; Synonyms=PKCG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Cui W.C., Yu L., Chu Y.Y., Wang J., Zheng L.H., Zhou G.J., Zhao S.Y.;
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-318.
RC   TISSUE=Brain;
RX   MEDLINE=86289426; PubMed=3755548; DOI=10.1126/science.3755548;
RA   Coussens L., Parker P.J., Rhee L., Yang-Feng T.L., Chen E.,
RA   Waterfield M.D., Francke U., Ullrich A.;
RT   "Multiple, distinct forms of bovine and human protein kinase C suggest
RT   diversity in cellular signaling pathways.";
RL   Science 233:859-866(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 162-697.
RC   TISSUE=Hippocampus;
RX   MEDLINE=93387312; PubMed=8375396;
RX   DOI=10.1111/j.1432-1033.1993.tb18179.x;
RA   Kochs G., Hummel R., Meyer D., Hug H., Marme D., Sarre T.F.;
RT   "Activation and substrate specificity of the human protein kinase C
RT   alpha and zeta isoenzymes.";
RL   Eur. J. Biochem. 216:597-606(1993).
RN   [5]
RP   INTERACTION WITH CDCP1.
RX   PubMed=15851033; DOI=10.1016/j.cell.2005.02.019;
RA   Benes C.H., Wu N., Elia A.E.H., Dharia T., Cantley L.C., Soltoff S.P.;
RT   "The C2 domain of PKCdelta is a phosphotyrosine binding domain.";
RL   Cell 121:271-280(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-655, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-514, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-197, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   STRUCTURE BY NMR OF 36-105.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the phorbol esters/diacylglycerol binding
RT   domain of protein kinase C gamma.";
RL   Submitted (DEC-2007) to the PDB data bank.
RN   [11]
RP   VARIANTS CYS-141; GLN-415; ASP-523 AND SER-659.
RX   MEDLINE=98213587; PubMed=9545390; DOI=10.1086/301819;
RA   Al-Maghtheh M., Vithana E.N., Inglehearn C.F., Moore T., Bird A.C.,
RA   Bhattacharya S.S.;
RT   "Segregation of a PRKCG mutation in two RP11 families.";
RL   Am. J. Hum. Genet. 62:1248-1252(1998).
RN   [12]
RP   SHOWS THAT THE VARIANTS ARE NOT A CAUSE OF RP11.
RX   MEDLINE=99375047; PubMed=10441600; DOI=10.1086/302554;
RA   Dryja T.P., McEvoy J., McGee T.L., Berson E.L.;
RT   "No mutations in the coding region of the PRKCG gene in three families
RT   with retinitis pigmentosa linked to the RP11 locus on chromosome
RT   19q.";
RL   Am. J. Hum. Genet. 65:926-928(1999).
RN   [13]
RP   VARIANTS SCA14 TYR-101; PRO-119 AND ASP-128.
RX   MEDLINE=22534985; PubMed=12644968; DOI=10.1086/373883;
RA   Chen D.-H., Brkanac Z., Verlinde C.L.M.J., Tan X.-J., Bylenok L.,
RA   Nochlin D., Matsushita M., Lipe H., Wolff J., Fernandez M.,
RA   Cimino P.J., Bird T.D., Raskind W.H.;
RT   "Missense mutations in the regulatory domain of PKC gamma: a new
RT   mechanism for dominant nonepisodic cerebellar ataxia.";
RL   Am. J. Hum. Genet. 72:839-849(2003).
CC   -!- FUNCTION: This is a calcium-activated, phospholipid-dependent,
CC       serine- and threonine-specific enzyme.
CC   -!- FUNCTION: PKC is activated by diacylglycerol which in turn
CC       phosphorylates a range of cellular proteins. PKC also serves as
CC       the receptor for phorbol esters, a class of tumor promoters.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Binds 3 calcium ions per subunit. The ions are bound to
CC       the C2 domain (By similarity).
CC   -!- SUBUNIT: Interacts with CDCP1.
CC   -!- DISEASE: Defects in PRKCG are the cause of spinocerebellar ataxia
CC       type 14 (SCA14) [MIM:605361]. Spinocerebellar ataxia is a
CC       clinically and genetically heterogeneous group of cerebellar
CC       disorders. Patients show progressive incoordination of gait and
CC       often poor coordination of hands, speech and eye movements, due to
CC       degeneration of the cerebellum with variable involvement of the
CC       brainstem and spinal cord. SCA14 is an autosomal dominant
CC       cerebellar ataxia (ADCA).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 C2 domain.
CC   -!- SIMILARITY: Contains 2 phorbol-ester/DAG-type zinc fingers.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Mutations of the PRKCG gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.com/sci-news/prkcgmut.htm";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PRKCG";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF345987; AAK13533.1; -; mRNA.
DR   EMBL; BC047876; AAH47876.1; -; mRNA.
DR   EMBL; M13977; AAA60102.1; ALT_TERM; mRNA.
DR   EMBL; Z15114; CAA78820.1; -; mRNA.
DR   IPI; IPI00007128; -.
DR   PIR; D24664; D24664.
DR   RefSeq; NP_002730.1; -.
DR   UniGene; Hs.631564; -.
DR   PDB; 2E73; NMR; -; A=36-105.
DR   PDB; 2UZP; X-ray; 2.00 A; A/B/C=154-295.
DR   PDBsum; 2E73; -.
DR   PDBsum; 2UZP; -.
DR   ProteinModelPortal; P05129; -.
DR   SMR; P05129; 93-158.
DR   DIP; DIP-39795N; -.
DR   IntAct; P05129; 6.
DR   MINT; MINT-222801; -.
DR   STRING; P05129; -.
DR   PhosphoSite; P05129; -.
DR   PeptideAtlas; P05129; -.
DR   PRIDE; P05129; -.
DR   Ensembl; ENST00000263431; ENSP00000263431; ENSG00000126583.
DR   GeneID; 5582; -.
DR   KEGG; hsa:5582; -.
DR   UCSC; uc002qcq.1; human.
DR   CTD; 5582; -.
DR   GeneCards; GC19P054382; -.
DR   H-InvDB; HIX0027463; -.
DR   HGNC; HGNC:9402; PRKCG.
DR   HPA; CAB013051; -.
DR   MIM; 176980; gene.
DR   MIM; 605361; phenotype.
DR   Orphanet; 98763; Spinocerebellar ataxia type 14.
DR   PharmGKB; PA33766; -.
DR   eggNOG; prNOG15770; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P05129; -.
DR   OMA; KGFLTKH; -.
DR   OrthoDB; EOG9SN471; -.
DR   PhylomeDB; P05129; -.
DR   BRENDA; 2.7.11.13; 247.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; retinoic_acid_pathway; Retinoic acid receptors-mediated signaling.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_15295; Opioid Signalling.
DR   Reactome; REACT_604; Hemostasis.
DR   NextBio; 21648; -.
DR   PMAP-CutDB; P05129; -.
DR   ArrayExpress; P05129; -.
DR   Bgee; P05129; -.
DR   CleanEx; HS_PRKCG; -.
DR   Genevestigator; P05129; -.
DR   GermOnline; ENSG00000126583; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:protein kinase C activity; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008219; P:cell death; IEA:UniProtKB-KW.
DR   GO; GO:0042177; P:negative regulation of protein catabolic pr...; IDA:HGNC.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:HGNC.
DR   GO; GO:0032425; P:positive regulation of mismatch repair; IDA:HGNC.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_Ca-dep.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR018029; C2_membr_targeting.
DR   InterPro; IPR020477; C2_region.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015745; PKC.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014375; Protein_kinase_C_a/b/g.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22985:SF86; PKC; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000550; PKC_alpha; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Calcium; Complete proteome;
KW   Disease mutation; Kinase; Metal-binding; Neurodegeneration;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Repeat;
KW   Serine/threonine-protein kinase; Spinocerebellar ataxia; Transferase;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    697       Protein kinase C gamma type.
FT                                /FTId=PRO_0000055689.
FT   DOMAIN      170    260       C2.
FT   DOMAIN      351    614       Protein kinase.
FT   DOMAIN      615    685       AGC-kinase C-terminal.
FT   ZN_FING      35     85       Phorbol-ester/DAG-type 1.
FT   ZN_FING     100    150       Phorbol-ester/DAG-type 2.
FT   NP_BIND     357    365       ATP (By similarity).
FT   ACT_SITE    480    480       Proton acceptor (By similarity).
FT   METAL       186    186       Calcium 1; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       187    187       Calcium 1 (By similarity).
FT   METAL       187    187       Calcium 2 (By similarity).
FT   METAL       193    193       Calcium 2 (By similarity).
FT   METAL       246    246       Calcium 1 (By similarity).
FT   METAL       246    246       Calcium 2 (By similarity).
FT   METAL       247    247       Calcium 2; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       248    248       Calcium 1 (By similarity).
FT   METAL       248    248       Calcium 2 (By similarity).
FT   METAL       248    248       Calcium 3 (By similarity).
FT   METAL       251    251       Calcium 3 (By similarity).
FT   METAL       252    252       Calcium 3; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       254    254       Calcium 1 (By similarity).
FT   METAL       254    254       Calcium 3 (By similarity).
FT   BINDING     380    380       ATP (By similarity).
FT   MOD_RES     195    195       Phosphotyrosine.
FT   MOD_RES     197    197       N6-acetyllysine.
FT   MOD_RES     312    312       Phosphotyrosine (By similarity).
FT   MOD_RES     322    322       Phosphoserine (By similarity).
FT   MOD_RES     330    330       Phosphoserine (By similarity).
FT   MOD_RES     514    514       Phosphothreonine.
FT   MOD_RES     518    518       Phosphothreonine (By similarity).
FT   MOD_RES     648    648       Phosphothreonine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     655    655       Phosphothreonine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     687    687       Phosphoserine (By similarity).
FT   VARIANT     101    101       H -> Y (in SCA14).
FT                                /FTId=VAR_017060.
FT   VARIANT     119    119       S -> P (in SCA14).
FT                                /FTId=VAR_017061.
FT   VARIANT     128    128       G -> D (in SCA14).
FT                                /FTId=VAR_017062.
FT   VARIANT     141    141       R -> C.
FT                                /FTId=VAR_008755.
FT   VARIANT     415    415       H -> Q.
FT                                /FTId=VAR_008756.
FT   VARIANT     523    523       A -> D.
FT                                /FTId=VAR_008757.
FT   VARIANT     659    659       R -> S.
FT                                /FTId=VAR_008758.
FT   STRAND      160    169
FT   STRAND      172    182
FT   STRAND      194    201
FT   STRAND      222    230
FT   HELIX       233    237
FT   STRAND      239    246
FT   STRAND      249    251
FT   STRAND      254    262
FT   HELIX       263    268
FT   STRAND      271    276
FT   HELIX       280    283
SQ   SEQUENCE   697 AA;  78448 MW;  3F911B5BEF713C41 CRC64;
     MAGLGPGVGD SEGGPRPLFC RKGALRQKVV HEVKSHKFTA RFFKQPTFCS HCTDFIWGIG
     KQGLQCQVCS FVVHRRCHEF VTFECPGAGK GPQTDDPRNK HKFRLHSYSS PTFCDHCGSL
     LYGLVHQGMK CSCCEMNVHR RCVRSVPSLC GVDHTERRGR LQLEIRAPTA DEIHVTVGEA
     RNLIPMDPNG LSDPYVKLKL IPDPRNLTKQ KTRTVKATLN PVWNETFVFN LKPGDVERRL
     SVEVWDWDRT SRNDFMGAMS FGVSELLKAP VDGWYKLLNQ EEGEYYNVPV ADADNCSLLQ
     KFEACNYPLE LYERVRMGPS SSPIPSPSPS PTDPKRCFFG ASPGRLHISD FSFLMVLGKG
     SFGKVMLAER RGSDELYAIK ILKKDVIVQD DDVDCTLVEK RVLALGGRGP GGRPHFLTQL
     HSTFQTPDRL YFVMEYVTGG DLMYHIQQLG KFKEPHAAFY AAEIAIGLFF LHNQGIIYRD
     LKLDNVMLDA EGHIKITDFG MCKENVFPGT TTRTFCGTPD YIAPEIIAYQ PYGKSVDWWS
     FGVLLYEMLA GQPPFDGEDE EELFQAIMEQ TVTYPKSLSR EAVAICKGFL TKHPGKRLGS
     GPDGEPTIRA HGFFRWIDWE RLERLEIPPP FRPRPCGRSG ENFDKFFTRA APALTPPDRL
     VLASIDQADF QGFTYVNPDF VHPDARSPTS PVPVPVM
//
